TY - JOUR
T1 - CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells
AU - Hasegawa, Masaki
AU - Hagiwara, Sumitaka
AU - Sato, Tomoko
AU - Jijiwa, Mayumi
AU - Murakumo, Yoshiki
AU - Maeda, Masahiro
AU - Moritani, Suzuko
AU - Ichihara, Shu
AU - Takahashi, Masahide
PY - 2007/5
Y1 - 2007/5
N2 - The CD109 gene encodes a glycosylphosphatidylinositol (GPI)-anchored cell surface protein. Herein it is shown that CD109 is highly expressed in myoepithelial cells of mammary, salivary, and lacrimal glands; and in prostate basal cells. The anti-CD109 antibody generated by the authors was available for formalin-fixed paraffin section, and it strongly stained myoepithelial cells and basal cells but not ductal, acinar, and secretory cells in these glands. CD109 expression was negative in examined breast ductal carcinomas and prostate adenocarcinomas. These findings indicate that CD109 is a useful marker for the diagnosis of invasive breast and prostate carcinomas.
AB - The CD109 gene encodes a glycosylphosphatidylinositol (GPI)-anchored cell surface protein. Herein it is shown that CD109 is highly expressed in myoepithelial cells of mammary, salivary, and lacrimal glands; and in prostate basal cells. The anti-CD109 antibody generated by the authors was available for formalin-fixed paraffin section, and it strongly stained myoepithelial cells and basal cells but not ductal, acinar, and secretory cells in these glands. CD109 expression was negative in examined breast ductal carcinomas and prostate adenocarcinomas. These findings indicate that CD109 is a useful marker for the diagnosis of invasive breast and prostate carcinomas.
UR - http://www.scopus.com/inward/record.url?scp=34247168696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34247168696&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1827.2007.02097.x
DO - 10.1111/j.1440-1827.2007.02097.x
M3 - Article
C2 - 17493171
AN - SCOPUS:34247168696
SN - 1320-5463
VL - 57
SP - 245
EP - 250
JO - Pathology International
JF - Pathology International
IS - 5
ER -